Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeraphim Space Regulatory News (SSIT)

Share Price Information for Seraphim Space (SSIT)

Share Price is delayed by 15 minutes
Get Live Data
187.00    -0.40 (-0.21%)
Bid:
186.60
Ask:
188.00
Spread: 1.40 (0.75%)
Market Cap: £443.56m
SSIT Live PriceLast checked at - London Stock Exchange

Intraday Seraphim Space Share Chart

Update from QuotedData

4 Dec 2025 16:15

RNS Number : 3407K
Seraphim Space Investment Trust PLC
04 December 2025
 

Seraphim Space Investment Trust - Update from QuotedData

5 December 2025

Dual-use SpaceTech: a strategic shift, not a short-term trend

Rising global defence spending, with many NATO countries now meeting or exceeding previous commitments, has made SpaceTech a higher priority for governments and major contractors. This shift in priorities is feeding directly into the commercial market. Investment in SpaceTech is also rebounding, with $10.4bn raised in the third quarter of 2025, close to the $10.9bn peak in the second quarter of 2021.

Seraphim Space Investment Trust (SSIT) is well positioned in dual-use SpaceTech and has seen strong NAV growth over the last year, helped by valuation uplifts across a number of core holdings. With several of SSIT's companies showing revenue growth, we believe there could be much more to come. This could help reduce SSIT's mid-30s discount to net asset value (NAV), which we see as far too wide.

Full Research:

https://quoteddata.com/research/seraphim-space-investment-trust-dual-use-spacetech-a-strategic-shift-not-a-short-term-trend-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Seraphim Space Investment Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUSRNRVWUURAA
Date   Source Headline
22nd Sep 20257:00 amRNSNotice of Results
10th Sep 20257:00 amRNS-RSpaceTech Sector Newsletter – August 2025
5th Aug 20257:00 amRNS-RSpaceTech Sector Newsletter – July 2025
3rd Jul 20257:00 amRNS-RSpaceTech Sector Newsletter – June 2025
25th Jun 20257:00 amRNS-RInvestor Meet Company Presentation
16th Jun 20257:00 amRNS-RMelloMonday Webinar
5th Jun 20257:00 amRNS-RSpaceTech Sector Newsletter – May 2025
4th Jun 20257:00 amRNSQ3 Results
22nd May 20255:02 pmRNSDirector/PDMR Shareholding
12th May 20252:34 pmRNSDirector/PDMR Shareholding
8th May 20257:00 amRNS-RSpaceTech Sector Newsletter – April 2025
1st May 20257:00 amRNSNotice of Results
17th Apr 20257:00 amRNS-RWhite Paper by Seraphim Space Manager LLP
4th Apr 20257:00 amRNS-RSpaceTech Sector Newsletter – March 2025
13th Mar 20257:00 amRNSInterim Results
4th Mar 20257:00 amRNS-RSpaceTech Sector Newsletter – February 2025
13th Feb 20257:00 amRNSNotice of Results
3rd Feb 20257:00 amRNS-RSpaceTech Sector Newsletter – January 2025
26th Nov 20241:52 pmRNSResults of AGM
26th Nov 20247:00 amRNSQ1 Results
31st Oct 20247:00 amRNSNotice of Results
21st Oct 20247:00 amRNSNotice of AGM
15th Oct 20241:39 pmRNSFull Year - Replacement
15th Oct 20247:00 amRNSFull Year Results
10th Oct 20247:00 amRNSDirector Declaration
8th Oct 20244:36 pmRNSHolding(s) in Company
9th Sep 20247:00 amRNSNotice of Results
6th Jun 20247:00 amRNSQ3 Results
3rd Jun 20247:00 amRNSSpaceTech Sector Newsletter – May 2024
13th May 20247:00 amRNSNotice of Results
2nd May 20247:00 amRNSSpaceTech Sector Newsletter – April 2024
22nd Apr 20247:00 amRNSSale of Early-Stage Portfolio Companies
10th Apr 202412:14 pmEQSEdison issues update on Seraphim Space Investment Trust (SSIT): Several key holdings funded to break-even
3rd Apr 20247:00 amRNSSpaceTech Sector Newsletter – March 2024
13th Mar 20242:18 pmRNSHolding(s) in Company - Replacement
13th Mar 20247:00 amRNSInterim Results
4th Mar 20247:00 amRNSSpaceTech Sector Newsletter - February 2024
26th Feb 20245:09 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSNotice of Results
5th Feb 20247:00 amRNSSpaceTech Sector Newsletter - January 2024
9th Jan 20247:00 amRNSSpaceTech Sector Newsletter – December 2023
5th Dec 20237:00 amRNSSpaceTech Sector Newsletter – November 2023
4th Dec 20232:43 pmEQSEdison issues update on Seraphim Space Investment Trust (SSIT): Spacetech enjoying sustained secular tailwinds
23rd Nov 20234:10 pmRNSDirector/PDMR Shareholding
20th Nov 20232:30 pmRNSResults of AGM
20th Nov 20237:00 amRNSQ1 Results
1st Nov 20237:00 amRNSSpaceTech Sector Newsletter October 2023
31st Oct 20237:00 amRNSNotice of Results
19th Oct 20237:00 amRNSNotice of AGM
17th Oct 20237:00 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.